Acute Market Reports pharmaceuticals report, Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Tarceva sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020).
The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.
Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.
Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.
Scope
• Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
• Analysis and review of Tarceva including sales data
• Qualitative and quantitative assessment of market space
• Analysis of the trends, drivers and restraints shaping and defining the markets
• In-depth analysis of Tarceva including efficacy, safety, pricing, competition and other details which influence its sales potential
• Detailed sales forecasts for 2004-2020 for Tarceva in the US, EU5 and Japan
• Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
• Analysis and review of Tarceva including sales data
• Qualitative and quantitative assessment of market space
• Analysis of the trends, drivers and restraints shaping and defining the markets
• In-depth analysis of Tarceva including efficacy, safety, pricing, competition and other details which influence its sales potential
• Detailed sales forecasts for 2004-2020 for Tarceva in the US, EU5 and Japan
View all reports of this category @ http://www.acutemarketreports.com/category/non-small-cell-lung-cancer-market
Reasons to buy
• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of competition by understanding the changing competitive landscape
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of the drugs performance
• Examine the historical sales performance of a drug in seven major markets
• Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of competition by understanding the changing competitive landscape
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of the drugs performance
• Examine the historical sales performance of a drug in seven major markets
• Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 NSCLC Market 4
2.2 Epidemiology 4
2.3 Etiology 6
2.3.1 Tobacco 6
2.3.2 Radon 6
2.3.3 Asbestos 6
2.3.4 Other Environmental Agents 7
2.4 GlobalData Report Guidance 8
2.1 NSCLC Market 4
2.2 Epidemiology 4
2.3 Etiology 6
2.3.1 Tobacco 6
2.3.2 Radon 6
2.3.3 Asbestos 6
2.3.4 Other Environmental Agents 7
2.4 GlobalData Report Guidance 8
3 NSCLC Disease: Market Characterization 9
3.1 NSCLC Disease Market 9
3.2 NSCLC Disease Market Forecasts and CAGR 9
3.3 Drivers for the NSCLC Disease Market 9
3.3.1 High Incidence 10
3.3.2 High Mortality Rate 11
3.3.3 Increased Use of Chemotherapy in Early Stages of NSCLC 11
3.3.4 Emergence of Targeted Drugs and Maintenance Therapy 11
3.3.5 Promising Pipeline Drugs 11
3.1 NSCLC Disease Market 9
3.2 NSCLC Disease Market Forecasts and CAGR 9
3.3 Drivers for the NSCLC Disease Market 9
3.3.1 High Incidence 10
3.3.2 High Mortality Rate 11
3.3.3 Increased Use of Chemotherapy in Early Stages of NSCLC 11
3.3.4 Emergence of Targeted Drugs and Maintenance Therapy 11
3.3.5 Promising Pipeline Drugs 11
4 Tumor-Node-Metastases (TNM) Classification of NSCLC 12
Click Here To Download Detail Report: http://www.acutemarketreports.com/request-free-sample/36916
5 Tarceva 15
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.4 Approval History of Tarceva 16
5.5 Factors Affecting Sales of Tarceva 16
5.5.1 NSCLC Market 16
5.5.2 Oral Administration 16
5.5.3 Maintenance Therapy 16
5.5.4 Mechanism of Action 16
5.5.5 Third-line treatment 17
5.5.6 Failure to get NICE Recommendation 17
5.6 Drug Risk Benefit Score 17
5.6.1 Efficacy 17
5.6.2 Safety 17
5.6.3 Compliance 18
5.6.4 Dosing Convenience 18
5.7 Intensity of Competition 18
5.8 Sales forecast 18
5.8.1 Target patient Pool of Tarceva 18
5.8.2 Dosing 19
5.8.3 Market Penetration 19
5.8.4 Annual Cost of Therapy 19
5.8.5 Sales Projections of Tarceva 20
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.4 Approval History of Tarceva 16
5.5 Factors Affecting Sales of Tarceva 16
5.5.1 NSCLC Market 16
5.5.2 Oral Administration 16
5.5.3 Maintenance Therapy 16
5.5.4 Mechanism of Action 16
5.5.5 Third-line treatment 17
5.5.6 Failure to get NICE Recommendation 17
5.6 Drug Risk Benefit Score 17
5.6.1 Efficacy 17
5.6.2 Safety 17
5.6.3 Compliance 18
5.6.4 Dosing Convenience 18
5.7 Intensity of Competition 18
5.8 Sales forecast 18
5.8.1 Target patient Pool of Tarceva 18
5.8.2 Dosing 19
5.8.3 Market Penetration 19
5.8.4 Annual Cost of Therapy 19
5.8.5 Sales Projections of Tarceva 20
6 NSCLC Market: Appendix 30
6.1 Market Definitions 30
6.2 List of Abberiviations 30
6.3 Research Methodology 30
6.3.1 Coverage 30
6.3.2 Secondary Research 31
6.3.3 Forecasting 31
6.3.4 Number of Patients Approved to take the Drug 31
6.3.5 Net Penetration of Drug 32
6.3.6 Net Annual Dosing 33
6.3.7 Annual Cost of Therapy 33
6.3.8 Primary Research 33
6.3.9 Expert Panels 33
6.4 Contact Us 34
6.5 Disclaimer 34
6.6 Sources 34
6.1 Market Definitions 30
6.2 List of Abberiviations 30
6.3 Research Methodology 30
6.3.1 Coverage 30
6.3.2 Secondary Research 31
6.3.3 Forecasting 31
6.3.4 Number of Patients Approved to take the Drug 31
6.3.5 Net Penetration of Drug 32
6.3.6 Net Annual Dosing 33
6.3.7 Annual Cost of Therapy 33
6.3.8 Primary Research 33
6.3.9 Expert Panels 33
6.4 Contact Us 34
6.5 Disclaimer 34
6.6 Sources 34
Latest Report: https://www.linkedin.com/pulse/global-polyphenylene-sulfide-market-review-regional-outlook-parmar
About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Blog: http://pharmaandhealthmarket.blogspot.com/
Website: Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Blog: http://pharmaandhealthmarket.blogspot.com/
Website: Acute Market Reports
No comments:
Post a Comment